treosulfan has been researched along with Lymphoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boysen, G; Danylesko, I; Nagler, A; Shimoni, A; Varda-Bloom, N | 1 |
| Avigdor, A; Danylesko, I; Nagler, A; Shem-Tov, N; Shimoni, A; Yerushalmi, R | 1 |
| Abedi-Valugerdi, M; Hassan, M; Pillai, PR; Sadeghi, B; Wolfsberger, J; Zhao, Y; Zheng, W | 1 |
| Aschan, J; Blau, I; Casper, J; Doelken, G; Freund, M; Giebel, S; Holowiecki, J; Knauf, W; Kroger, N; Ruutu, T; Schafer-Eckart, K; Volin, L; Wandt, H; Zander, A | 1 |
| Becker, E; Casper, J; Franke, A; Freund, M; Heim, M; Jentsch-Ullrich, K; Koenigsmann, M; Mohren, M | 1 |
| Ersbøll, J; Keiding, N; Larsen, MS; Larsen, SO; Nissen, NI; Pedersen-Bjergaard, J; Philip, P; Schultz, H; Sørensen, HM | 1 |
3 trial(s) available for treosulfan and Lymphoma
| Article | Year |
|---|---|
Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies.
Topics: Adolescent; Adult; Aged; Allografts; Busulfan; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphoma; Male; Middle Aged; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Vidarabine | 2015 |
Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation.
Topics: Busulfan; Humans; Leukemia; Leukemia, Myeloid, Acute; Leukocyte Transfusion; Lymphoma; Myelodysplastic Syndromes; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2004 |
High-dose treosulfan in patients with relapsed or refractory high-grade lymphoma receiving tandem autologous blood stem cell transplantation.
Topics: Adult; Antineoplastic Agents, Alkylating; Busulfan; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma; Male; Middle Aged; Recurrence; Stem Cell Transplantation; Transplantation, Autologous | 2004 |
3 other study(ies) available for treosulfan and Lymphoma
| Article | Year |
|---|---|
A simplified method for detection of N-terminal valine adducts in patients receiving treosulfan.
Topics: Adult; Aged; Busulfan; Chromatography, Liquid; Female; Hemoglobins; Humans; Leukemia; Lymphoma; Male; Middle Aged; Stem Cell Transplantation; Tandem Mass Spectrometry; Transplantation Conditioning; Transplantation, Homologous; Valine; Young Adult | 2019 |
Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Busulfan; Cell Line, Tumor; Drug Interactions; Female; Fluorouracil; Immunosuppressive Agents; Leukocyte Count; Lymphoma; Mice, Inbred C57BL; Myeloid Cells; Spleen; Tumor Burden | 2016 |
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
Topics: Acute Disease; Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Infant; Leukemia; Lymphoma; Male; Mechlorethamine; Middle Aged; Myeloproliferative Disorders; Nitrosourea Compounds; Ovarian Neoplasms; Preleukemia; Risk; Time Factors | 1985 |